GO:1904075 positive regulation of trophectodermal cell proliferation: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904075 describes any process that activates or increases the frequency, rate, or extent of trophectodermal cell proliferation, a critical step in preimplantation embryo development.
• Trophectoderm proliferation is regulated by growth factors such as FGF2, FGF7, FGF9, WNT, and TGFB1, which are expressed in the uterus and embryo during early pregnancy.
• The transcription factor Cdx2 is a key marker of trophectoderm specification and its expression is linked to the loss of totipotency in outer blastomeres.
• Dysregulation of trophectoderm proliferation can affect embryo viability, implantation, and pregnancy outcomes, with implications for livestock reproduction and human fertility.
• Research tools such as CRISPR knockout, knock-in, overexpression, and library screening enable functional dissection of genes that positively regulate trophectodermal cell proliferation.
• Understanding GO:1904075 provides insights into early embryonic development and may inform assisted reproductive technologies and stem cell derivation.
Description
Trophectodermal cell proliferation is a fundamental process during preimplantation embryo development, giving rise to the outer epithelial layer that later forms the placenta. The Gene Ontology term GO:1904075, positive regulation of trophectodermal cell proliferation, encompasses any process that activates or increases the frequency, rate, or extent of this proliferation. This term is essential for researchers studying early embryogenesis, as the trophectoderm is the first differentiated lineage to emerge, and its proper expansion is required for blastocyst formation and implantation. Disruption of trophectoderm proliferation can lead to developmental failure, making its positive regulators key targets for reproductive biology and regenerative medicine. Several signaling pathways and growth factors have been implicated in positively regulating trophectodermal cell proliferation. For instance, WNT signaling promotes the development of the preimplantation bovine embryo, influencing trophectoderm proliferation. Fibroblast growth factor 2 (FGF2) promotes primitive endoderm development in bovine blastocyst outgrowths, indirectly affecting trophectoderm expansion. FGF9 is expressed in the mouse uterus during early pregnancy, suggesting a role in embryo-maternal communication that may influence trophectoderm proliferation. Additionally, progestogen supplementation during superovulation in sheep increases embryo viability and TGFB1 expression, which may positively regulate trophectoderm proliferation. Leptin treatment of in vitro cultured embryos increases the outgrowth rate of the inner cell mass during embryonic stem cell derivation, highlighting metabolic influences on early lineage proliferation. Understanding the positive regulation of trophectodermal cell proliferation is crucial for both basic developmental biology and applied reproductive technologies. The transcription factor Cdx2 is a key marker of trophectoderm specification, and its expression in outer blastomeres correlates with the loss of totipotency after the fifth cleavage division. Gadd45g has been shown to initiate embryonic stem cell differentiation, which may intersect with trophectoderm lineage commitment. Moreover, fibroblast growth factor 7 (FGF7) expression in the pig uterus is regulated by progesterone and estradiol, indicating hormonal control of factors that could influence trophectoderm proliferation. These findings underscore the complexity of the regulatory network and the need for precise experimental models to dissect causal relationships.
positive regulation of trophectodermal cell proliferation At A Glance
| GO ID | GO:1904075 |
|---|---|
| GO term | positive regulation of trophectodermal cell proliferation |
| Ontology | biological_process |
| Synonym | activation of trophectodermal cell proliferation; activation of trophectoderm cell proliferation; positive regulation of trophectoderm cell proliferation; up regulation of trophectodermal cell proliferation; up-regulation of trophectodermal cell proliferation; upregulation of trophectodermal cell proliferation; up regulation of trophectoderm cell proliferation; up-regulation of trophectoderm cell proliferation; upregulation of trophectoderm cell proliferation |
| Major function | Increases the proliferation of trophectoderm cells, the outer epithelial layer of the blastocyst, which is critical for implantation and placental formation. |
| Related processes | Blastocyst formation, trophectoderm specification, embryo implantation, and early lineage differentiation. |
| Key regulators | WNT signaling, FGF2, FGF7, FGF9, TGFB1, progesterone, estradiol, and Cdx2. |
| Research relevance | Implications for fertility, livestock reproduction, stem cell derivation, and developmental disorders. |
What Is GO:1904075?
GO:1904075, positive regulation of trophectodermal cell proliferation, is a biological process term defined as any process that activates or increases the frequency, rate, or extent of trophectodermal cell proliferation. In simpler terms, it covers all molecular events and signals that boost the multiplication of trophectoderm cells, the outer cell layer of the blastocyst that is essential for implantation and placental development.
Why Is positive regulation of trophectodermal cell proliferation Important in Cell Biology?
The positive regulation of trophectodermal cell proliferation is a cornerstone of early embryonic development because the trophectoderm is the first extraembryonic lineage to differentiate and is indispensable for implantation and placentation. Understanding how this process is activated can reveal mechanisms of embryo viability, improve assisted reproductive technologies, and shed light on developmental disorders linked to implantation failure.
• Trophectoderm proliferation is required for blastocyst expansion and hatching, a prerequisite for implantation.
• Positive regulators such as WNT and FGF signaling are conserved across mammalian species, including bovine and mouse models.
• Hormonal cues like progesterone and estradiol regulate uterine expression of growth factors that may act on the trophectoderm.
• Cdx2 expression marks trophectoderm specification and its dysregulation can lead to failed lineage segregation.
• Leptin treatment enhances inner cell mass outgrowth, suggesting metabolic regulation of early lineage proliferation.
• Gadd45g initiates embryonic stem cell differentiation, potentially influencing trophectoderm commitment.
• Abnormal trophectoderm proliferation is associated with early pregnancy loss and reduced embryo viability in livestock.
• Studying GO:1904075 aids in optimizing in vitro embryo culture conditions for research and clinical applications.
• CRISPR-based screens can identify novel positive regulators of trophectodermal cell proliferation.
• This process is a model for understanding how signaling pathways control tissue-specific stem cell proliferation.
What Happens During positive regulation of trophectodermal cell proliferation?
Initiation by Growth Factor Signaling
In simple terms: Growth factors tell trophectoderm cells to start dividing.
Positive regulation begins when extracellular growth factors, such as FGF2, FGF7, FGF9, or WNT ligands, bind to receptors on trophectoderm cells or adjacent cells, triggering intracellular signaling cascades. In the pig uterus, FGF7 expression is regulated by progesterone and estradiol, suggesting hormonal control of growth factor availability. Similarly, progestogen supplementation in sheep increases TGFB1 expression, which may act as a positive regulator.
Activation of Intracellular Pathways
In simple terms: Signals inside the cell switch on genes that drive cell division.
Upon receptor activation, pathways such as WNT/β-catenin and MAPK are engaged, leading to the activation of transcription factors that promote cell cycle progression. For example, WNT signaling promotes development of the preimplantation bovine embryo, likely by enhancing trophectoderm proliferation. FGF2 promotes primitive endoderm development in bovine blastocyst outgrowths, which may indirectly support trophectoderm expansion through paracrine signals.
Transcriptional Control of Proliferation Genes
In simple terms: Master switches turn on genes needed for cell division.
Transcription factors such as Cdx2 are critical for trophectoderm specification and maintenance of the proliferative state. Cdx2 expression in outer blastomeres coincides with the loss of totipotency after the fifth cleavage division, marking the commitment to the trophectoderm lineage. Other factors like Gadd45g can initiate differentiation programs that may intersect with trophectoderm proliferation.
Cell Cycle Progression and Proliferation
In simple terms: Cells actually divide and increase in number.
The ultimate outcome of positive regulation is an increase in the frequency, rate, or extent of trophectodermal cell proliferation. This involves progression through the cell cycle, DNA replication, and mitosis, leading to expansion of the trophectoderm layer. Leptin treatment of in vitro cultured embryos increases the outgrowth rate of the inner cell mass, indicating that metabolic signals can enhance proliferative capacity of early lineages.
Integration with Embryo Development
In simple terms: The extra cells help the embryo grow and implant.
Enhanced trophectoderm proliferation contributes to blastocyst expansion, hatching from the zona pellucida, and implantation. Proper regulation ensures a sufficient number of trophectoderm cells for placental formation. Disruption of positive regulators can lead to reduced embryo viability, as seen in studies where WNT signaling modulation affects bovine embryo development.
Key Genes Involved in GO:1904075 positive regulation of trophectodermal cell proliferation
The following genes and proteins have been experimentally linked to the positive regulation of trophectodermal cell proliferation or related early embryonic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Cdx2 | Transcription factor essential for trophectoderm specification and maintenance | Marker of trophectoderm lineage; loss leads to failed lineage segregation |
| FGF2 | Growth factor promoting primitive endoderm development in blastocyst outgrowths | May indirectly support trophectoderm proliferation via paracrine signaling |
| FGF7 | Growth factor expressed in uterus under hormonal control | Regulated by progesterone and estradiol; potential mediator of embryo-maternal communication |
| FGF9 | Growth factor expressed in uterus during early pregnancy | Spatial and temporal expression suggests role in early embryo development |
| TGFB1 | Growth factor increased by progestogen supplementation | Associated with higher embryo viability in sheep |
| WNT ligands | Secreted signaling molecules | WNT signaling promotes preimplantation bovine embryo development |
| Gadd45g | Initiates embryonic stem cell differentiation | May influence trophectoderm commitment |
| Leptin | Metabolic hormone | Treatment increases inner cell mass outgrowth in vitro |
| Oct4 | Pluripotency transcription factor | Expression lost in outer blastomeres as they become trophectoderm |
| Progesterone | Steroid hormone | Regulates FGF7 expression in pig uterus |
| Estradiol | Steroid hormone | Regulates FGF7 expression in pig uterus |
| β-catenin | WNT signaling effector | Mediates WNT effects on embryo development |
| MAPK | Intracellular kinase pathway | Downstream of FGF signaling; may regulate proliferation |
| CDX2 | Homeobox transcription factor | Key regulator of trophectoderm differentiation |
| FGF receptor | Receptor tyrosine kinase | Mediates FGF signaling in early embryos |
| TGFB receptor | Serine/threonine kinase receptor | Mediates TGFB1 signaling |
How Is positive regulation of trophectodermal cell proliferation Regulated?
The positive regulation of trophectodermal cell proliferation is controlled by a network of hormonal and growth factor signals. Progesterone and estradiol regulate the expression of FGF7 in the pig uterus, thereby influencing the availability of this growth factor to the embryo. Progestogen supplementation during superovulation in sheep leads to higher embryo viability and increased TGFB1 gene expression, suggesting that hormonal treatments can modulate positive regulators. WNT signaling is another key pathway; modulation of endogenous and exogenous WNT affects preimplantation bovine embryo development, likely by altering trophectoderm proliferation. Additionally, metabolic signals such as leptin can enhance outgrowth of the inner cell mass, indicating that nutrient status may impact early lineage proliferation. These regulatory inputs converge on transcription factors like Cdx2, which orchestrates the gene expression program for trophectoderm proliferation and differentiation.
positive regulation of trophectodermal cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Cdx2 | Implantation failure, placental defects | Knockout mouse embryos; trophectoderm-specific conditional KO |
| WNT signaling components | Embryo viability, early pregnancy loss | Bovine embryo culture with WNT modulators |
| TGFB1 | Embryo viability in livestock | Sheep superovulation model with progestogen supplementation |
| FGF7 | Uterine receptivity, embryo-maternal communication | Pig model with hormonal treatments |
| Leptin | Metabolic regulation of embryo development | In vitro cultured embryos with leptin treatment |
Implantation Failure and Infertility
Defects in trophectoderm proliferation can lead to failure of blastocyst implantation, a major cause of early pregnancy loss in humans and livestock. Proper positive regulation is required for the trophectoderm to expand and form a functional placenta. Studies in bovine embryos show that WNT signaling, which promotes trophectoderm proliferation, is critical for development; its dysregulation reduces embryo viability. Similarly, in sheep, progestogen supplementation improves embryo viability and TGFB1 expression, highlighting the importance of hormonal regulation.
Developmental Disorders and Stem Cell Derivation
Abnormal trophectoderm proliferation may contribute to developmental disorders affecting the placenta. The transcription factor Cdx2 is essential for trophectoderm specification, and its misexpression can disrupt lineage segregation. In stem cell research, leptin treatment enhances inner cell mass outgrowth during embryonic stem cell derivation, suggesting that metabolic regulation of early lineages can be manipulated for regenerative purposes. Gadd45g, which initiates embryonic stem cell differentiation, may also influence trophectoderm commitment, linking cell cycle control to lineage decisions.
Livestock Reproduction and Agricultural Impact
In livestock, efficient trophectoderm proliferation is directly tied to embryo viability and reproductive success. FGF7 expression in the pig uterus is regulated by progesterone and estradiol, and manipulation of these hormones can affect embryo development. FGF9 expression in the mouse uterus during early pregnancy suggests conserved mechanisms that could be targeted to improve reproductive outcomes in animals. Understanding these pathways can lead to better superovulation protocols and embryo transfer success.
From positive regulation of trophectodermal cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate trophectoderm proliferation? | CRISPR knockout in mouse embryos or embryonic stem cells |
| What is the effect of a point mutation in gene X on trophectoderm proliferation? | CRISPR point mutation knock-in in zygotes |
| How does tagging gene X affect its localization and function? | Knock-in of fluorescent tag (e.g., GFP) in trophectoderm cells |
| Does overexpression of gene X enhance trophectoderm proliferation? | Transgenic overexpression or mRNA injection in embryos |
| Which genes are essential for trophectoderm proliferation? | CRISPR library screening in embryonic stem cells or blastoids |
| How does hormonal signaling affect trophectoderm proliferation? | In vitro embryo culture with progesterone/estradiol |
How to Study the positive regulation of trophectodermal cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify upregulated pathways in trophectoderm after growth factor treatment |
| Single-cell RNA-seq | Transcriptomes of individual cells | Profile trophectoderm vs inner cell mass lineages |
| CRISPR knockout screening | Loss-of-function effects on proliferation | Discover essential positive regulators |
| CRISPR overexpression screening | Gain-of-function effects on proliferation | Identify genes that enhance trophectoderm proliferation |
| Immunofluorescence | Protein localization and expression | Detect Cdx2, β-catenin in blastocysts |
| Live imaging | Real-time cell division and expansion | Track trophectoderm proliferation in cultured embryos |
| Western blot | Protein levels and phosphorylation | Measure activation of WNT/MAPK pathways |
| Embryo culture with treatments | Developmental outcomes | Test effects of hormones/growth factors on proliferation |
Transcriptomic Analysis (RNA-seq)
RNA sequencing can profile gene expression changes in trophectoderm cells under conditions that positively regulate proliferation. For example, comparing embryos treated with WNT activators or growth factors to controls can reveal upregulated pathways. Single-cell RNA-seq of blastocysts can identify trophectoderm-specific transcripts and their regulation.
Imaging and Lineage Tracing
Live imaging of fluorescently labeled trophectoderm cells allows real-time monitoring of proliferation and expansion. Knock-in of fluorescent reporters for Cdx2 or other markers enables tracking of trophectoderm lineage specification and proliferation in developing embryos.
CRISPR-Based Functional Screens
Pooled CRISPR knockout screens in embryonic stem cells or trophectoderm-like cells can identify genes whose loss reduces proliferation. Conversely, overexpression screens can find positive regulators. These screens are powerful for discovering novel components of GO:1904075.
Protein and Signaling Assays
Western blotting, immunostaining, and kinase activity assays can measure activation of signaling pathways (e.g., WNT, MAPK) that positively regulate trophectoderm proliferation. Such methods validate the molecular mechanisms downstream of growth factor stimulation.
How CRISPR Can Be Used to Study GO:1904075 positive regulation of trophectodermal cell proliferation
Knockout
CRISPR knockout of candidate positive regulators (e.g., Cdx2, FGF receptors) in mouse zygotes or embryonic stem cells can test their requirement for trophectoderm proliferation. Loss of Cdx2 leads to failed trophectoderm specification and reduced proliferation. Such models help establish causality.
Point Mutation
Introducing specific point mutations (e.g., in signaling domains of growth factor receptors) via CRISPR can dissect which residues are critical for positive regulation. This approach is useful for mimicking human variants or testing phosphorylation sites.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags into endogenous loci allows visualization and biochemical analysis of proteins involved in trophectoderm proliferation. For example, tagging Cdx2 enables live tracking of trophectoderm lineage.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can drive candidate genes to test whether they are sufficient to enhance trophectoderm proliferation. Overexpression of WNT components or growth factors may increase proliferation.
How EDITGENE Supports positive regulation of trophectodermal cell proliferation Research
Researchers studying positive regulation of trophectodermal cell proliferation-related genes often need to determine whether a candidate gene is causally involved in this process or merely correlated. Functional validation through precise genome editing is essential to establish causality and to explore therapeutic or biotechnological applications.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of trophectodermal cell proliferation research.
Frequently Asked Questions About positive regulation of trophectodermal cell proliferation
What is GO:1904075?
GO:1904075 is the Gene Ontology term for positive regulation of trophectodermal cell proliferation, describing any process that increases the frequency, rate, or extent of trophectoderm cell division.
What genes are involved in positive regulation of trophectodermal cell proliferation?
Key genes include Cdx2, FGF2, FGF7, FGF9, TGFB1, WNT signaling components, and Gadd45g, among others.
How is trophectoderm proliferation regulated?
It is regulated by hormonal signals (progesterone, estradiol), growth factors (FGFs, WNT, TGFB1), and transcription factors like Cdx2 that control cell cycle genes.
Why is trophectoderm proliferation important for embryo implantation?
Trophectoderm proliferation expands the outer cell layer, enabling blastocyst hatching and implantation into the uterus, which is essential for pregnancy.
What research methods study positive regulation of trophectodermal cell proliferation?
Methods include RNA-seq, single-cell RNA-seq, CRISPR screens, immunofluorescence, live imaging, and embryo culture with growth factor treatments.
Can CRISPR be used to study trophectoderm proliferation?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models allow functional dissection of genes in this process.
What diseases are linked to abnormal trophectoderm proliferation?
Implantation failure, early pregnancy loss, and placental defects are associated with dysregulation of this process.
Which signaling pathways positively regulate trophectodermal cell proliferation?
WNT, FGF, and TGFB1 pathways have been shown to promote trophectoderm proliferation in various species.
How does Cdx2 relate to GO:1904075?
Cdx2 is a transcription factor essential for trophectoderm specification and maintenance; its expression marks cells that will proliferate to form the trophectoderm.
What model organisms are used to study trophectodermal cell proliferation?
Mouse, bovine, pig, and sheep embryos are commonly used, as well as embryonic stem cells and in vitro culture systems.
Conclusion
GO:1904075, positive regulation of trophectodermal cell proliferation, is a vital biological process in early embryonic development. It integrates hormonal, growth factor, and transcriptional signals to ensure proper expansion of the trophectoderm, which is required for implantation and placental formation. Dysregulation of this process can lead to infertility and pregnancy loss, making it a key area of research in reproductive biology. Advances in CRISPR genome editing and functional genomics provide powerful tools to identify and characterize the genes that positively regulate trophectodermal cell proliferation, offering potential for improving assisted reproduction and livestock breeding.
References
- 1. Zhang X et al.. 2021. Gadd45g initiates embryonic stem cell differentiation and inhibits breast cell carcinogenesis.. Cell Death Discov 7(1):271 PMID: 34601500
- 2. Ka H et al.. 2007. Regulation of expression of fibroblast growth factor 7 in the pig uterus by progesterone and estradiol.. Biol Reprod 77(1):172-80 PMID: 17392499
- 3. Tribulo P et al.. 2017. Consequences of endogenous and exogenous WNT signaling for development of the preimplantation bovine embryo.. Biol Reprod 96(6):1129-1141 PMID: 28575156
- 4. Taskin AC et al.. 2019. Leptin treatment of in vitro cultured embryos increases outgrowth rate of inner cell mass during embryonic stem cell derivation.. In Vitro Cell Dev Biol Anim 55(7):473-481 PMID: 31214928
- 5. Taira AR et al.. 2022. Progestogen supplementation during superovulation leads to higher embryo viability and TGFB1 gene expression in sheep.. Anim Reprod Sci 238:106938 PMID: 35124431
- 6. Suwińska A et al.. 2008. Blastomeres of the mouse embryo lose totipotency after the fifth cleavage division: expression of Cdx2 and Oct4 and developmental potential of inner and outer blastomeres of 16- and 32-cell embryos.. Dev Biol 322(1):133-44 PMID: 18692038
- 7. Yang QE et al.. 2011. Fibroblast growth factor 2 promotes primitive endoderm development in bovine blastocyst outgrowths.. Biol Reprod 85(5):946-53 PMID: 21778141
- 8. Šućurović S et al.. 2017. Spatial and Temporal Analyses of FGF9 Expression During Early Pregnancy.. Cell Physiol Biochem 42(6):2318-2329 PMID: 28848153
